Ads
related to: rituximab protocol for pemphigus treatment in adults older- Symptom & Condition Info
Understand The Causes & Symptoms of
gMG. Get Condition Information.
- Access Savings Info
Eligible Patients May Qualify For
Financial Assistance. Learn More.
- Find An Infusion Center
Learn About Treatment And
Locate The Nearest Infusion Center.
- Patient Resources
Download Brochures. Connect With
The gMG Community & Support Groups.
- Symptom & Condition Info
Search results
Results From The WOW.Com Content Network
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...
Pemphigus vulgaris is a rare chronic blistering skin disease and the most common form of pemphigus.Pemphigus was derived from the Greek word pemphix, meaning blister. [1] It is classified as a type II hypersensitivity reaction in which antibodies are formed against desmosomes, components of the skin that function to keep certain layers of skin bound to each other.
Bullous pemphigoid (a type of pemphigoid) is an autoimmune pruritic skin disease that typically occurs in people aged over 60, that may involve the formation of blisters in the space between the epidermal and dermal skin layers.
Roche (RHHBY) announces positive data on rheumatic diseases drug, Rituxan, for pemphigus vulgaris. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290 ...
6-30 per 100,000 (mostly older adults) [7] Cicatricial pemphigoid: Mucous membranes, sometimes skin Anti-BP180, Anti-BP230 Confirmed Rare [8] Dermatitis herpetiformis: Skin Anti-tissue transglutaminase: Confirmed 10 per 100,000 [9] Dermatomyositis: Skin and muscles: Anti-Jo1, Anti-Mi2, Anti-SRP, Anti-TIF1 Confirmed 9 in 1,000,000 [10] Discoid ...
[17] [18] Currently rituximab is considered a first-line treatment for some pemphigus patients according to Delphi consensus recommendations [19] All of these drugs may cause severe side effects, so patients should be closely monitored by doctors. Once the outbreaks are under control, dosage is often reduced, to lessen side effects.
Ads
related to: rituximab protocol for pemphigus treatment in adults older